Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-325,124
Closed -$1.95M – 4134
2026
Q1
$1.95M Buy
+325,124
New +$2.15M ﹤0.01% 1635
2025
Q4
– Sell
-667,082
Closed -$3.67M – 3144
2025
Q3
$3.67M Buy
+667,082
New +$3.62M 0.01% 817
2025
Q2
– Sell
-195,006
Closed -$957K – 2566
2025
Q1
$957K Buy
+195,006
New +$1.05M 0.01% 1129
2024
Q2
– Sell
-133,507
Closed -$974K – 2186
2024
Q1
$974K Buy
+133,507
New +$1.14M 0.01% 898
2023
Q4
– Sell
-382,899
Closed -$1.56M – 2285
2023
Q3
$1.56M Buy
+382,899
New +$1.49M 0.02% 734
2023
Q2
– Sell
-598,634
Closed -$2.87M – 2432
2023
Q1
$2.87M Sell
598,634
-74,450
-11% -$251K 0.04% 441
2022
Q4
$1.92M Buy
+673,084
New +$1.14M 0.03% 614
2021
Q4
– Sell
-124,797
Closed -$164K – 3141
2021
Q3
$164K Buy
+124,797
New +$333K ﹤0.01% 2756
2021
Q1
– Sell
-10,500
Closed -$67K – 2664
2020
Q4
$67K Buy
+10,500
New +$62.3K ﹤0.01% 1675
2019
Q1
– Sell
-16,480
Closed -$29K – 502
2018
Q4
$29K Buy
+16,480
New +$48.5K ﹤0.01% 546

Other funds holding ARDX

HRT Financial's ARDX Position: Q2 2026 in Review

HRT Financial sold out of Ardelyx (ARDX) in Q2 2026, closing a stake of 325,124 shares — an estimated $1.95M sold.

HRT Financial first reported a position in ARDX in Q4 2018 and held it in 10 quarters. The position peaked at $3.67M in Q3 2025. 250 funds tracked by Wall St. Rank hold ARDX as of Q2 2026.

  • HRT Financial reported no remaining Ardelyx position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 325,124 Ardelyx shares in Q2 2026, an estimated $1.95M.
  • HRT Financial first reported a position in Ardelyx in Q4 2018 and held it in 10 quarters.
  • HRT Financial's Ardelyx position peaked at $3.67M in Q3 2025.
  • 250 funds tracked by Wall St. Rank held Ardelyx as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.